Characterizing HIV-1 reservoirs in the central nervous system

中枢神经系统中 HIV-1 储存库的特征

基本信息

  • 批准号:
    10772268
  • 负责人:
  • 金额:
    $ 83.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-04-30
  • 项目状态:
    未结题

项目摘要

Abstract A considerable number of clinical, neuropathological, immunohistochemical and immunological studies suggest that human brain cells, in particular those of myeloid origin, are susceptible to HIV-1 infection; infection of these cells may contribute to neurocognitive dysfunction and viral long-term persistence despite ART. However, among all anatomical tissue locations in the human body, the central nervous system (CNS) arguably represents the most difficult one to access and to evaluate for viral infection and persistence. Recently, we and others have made significant progress in defining viral reservoirs at a single-cell and single-molecule resolution, using a platform of novel next-generation sequencing assays allowing to simultaneously analyzing near full-length proviral sequences, the corresponding chromosomal integration sites and the respective HIV-1 RNA expression profile from individual viral reservoir cells. Using such technologies, we observed evidence for immune-mediated selection mechanisms that enable long-term persistence of viral reservoir cells with features of deep latency, while reservoir cells with higher susceptibility to reactivation signals seemed to be actively selected against; in rare cases of individuals with “elite control”, such selection mechanism resulted in a highly-restricted viral reservoir configuration consisting of intact proviruses located in heterochromatin positions not permissive to viral transcription. Here we will propose to use this established and fully-operational technology pipeline for a detailed analysis of the frequency, clonality and replication competence of proviruses isolated from sorted CNS cells, in particular from myeloid parenchymal microglia, from myeloid perivascular macrophages and astrocytes (Specific Aim 1). In addition, we will utilize novel next-generation sequencing assays for characterizing the chromosomal locations of intact and defective proviruses, and their associated epigenetic chromatin microenvironment, using ATAC-Seq, ChIP-Seq and Methylation-Seq assays (Specific Aim 2). For a functional evaluation of proviruses residing in the CNS, we will subsequently conduct reactivation assays with single patient-derived virally-infected cells from the CNS, allowing us to determine how chromosomal positioning and epigenetic features affect the transcriptional activity of proviruses and their susceptibility to latency-reversing agents (Specific Aim 3). Together, these investigations will provide high-resolution insight into the dynamics of HIV-1 persistence in myeloid CNS cell subsets and may be highly informative for targeted HIV-1 cure interventions.
摘要 大量的临床、神经病理学、免疫组化和免疫学研究表明, 人类的脑细胞,特别是骨髓来源的脑细胞,易受HIV-1感染; 细胞可能导致神经认知功能障碍和病毒长期持续存在,尽管艺术。 在人体的所有解剖组织位置中,中枢神经系统(CNS)可以说代表了 最难接近和评估病毒感染和持久性的一种。最近,我们和其他人 在单细胞和单分子分辨率下定义病毒储库方面取得了重大进展, 新一代测序分析平台,允许同时分析近全长 前病毒序列、相应的染色体整合位点和各自的HIV-1 RNA表达 来自单个病毒储库细胞的特征。使用这些技术,我们观察到免疫介导的 选择机制使具有深潜伏特征的病毒储存细胞能够长期持续, 而对再激活信号具有更高敏感性的储库细胞似乎被主动选择; 罕见的情况下,个体与“精英控制”,这种选择机制导致了高度限制的病毒 由位于异染色质位置的完整前病毒组成的储存库构型,不允许病毒感染 转录。在这里,我们将建议使用这一已建立和全面运作的技术管道, 分析从分选的CNS细胞中分离的前病毒的频率、克隆性和复制能力, 特别是来自骨髓实质小胶质细胞、来自骨髓血管周围巨噬细胞和星形胶质细胞 (具体目标1)。此外,我们将利用新的下一代测序分析来表征 完整和缺陷前病毒的染色体定位及其相关的表观遗传染色质 使用ATAC-Seq、ChIP-Seq和甲基化-Seq测定(特异性目的2),在微环境中测定细胞的DNA。某功能 为了评估CNS中存在的前病毒,我们随后将用单个 患者来源的病毒感染的细胞从中枢神经系统,使我们能够确定如何染色体定位和 表观遗传特征影响前病毒的转录活性及其对潜伏期逆转的敏感性 具体目标(3)。总之,这些调查将提供高分辨率的动态洞察力, HIV-1在髓样CNS细胞亚群中的持续存在,可能为靶向HIV-1治疗提供高度信息 干预措施。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shibani Sharon Mukerji其他文献

Shibani Sharon Mukerji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shibani Sharon Mukerji', 18)}}的其他基金

In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
  • 批准号:
    10535147
  • 财政年份:
    2022
  • 资助金额:
    $ 83.47万
  • 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
  • 批准号:
    10843494
  • 财政年份:
    2022
  • 资助金额:
    $ 83.47万
  • 项目类别:
In Vivo Targeting of Neuroactive Steroid and Immune Networks for Depression in People Living with HIV.
体内靶向神经活性类固醇和免疫网络治疗艾滋病毒感染者的抑郁症。
  • 批准号:
    10701054
  • 财政年份:
    2022
  • 资助金额:
    $ 83.47万
  • 项目类别:
Immune Activation, Cerebral Metabolic Activity and Depression in Treated HIV-Infection
HIV 感染治疗中的免疫激活、大脑代谢活动和抑郁
  • 批准号:
    10339397
  • 财政年份:
    2018
  • 资助金额:
    $ 83.47万
  • 项目类别:
Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
  • 批准号:
    7670508
  • 财政年份:
    2007
  • 资助金额:
    $ 83.47万
  • 项目类别:
Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
  • 批准号:
    7275205
  • 财政年份:
    2007
  • 资助金额:
    $ 83.47万
  • 项目类别:
Activin in cerebral hypoxia and acute focal ischemia
激活素在脑缺氧和急性局灶性缺血中的作用
  • 批准号:
    7677913
  • 财政年份:
    2007
  • 资助金额:
    $ 83.47万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 83.47万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了